Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Kato (Hong Kong) Holdings Limited (2189.HK)
Tuen Mun, HK
Kato (Hong Kong) Holdings Limited, an investment holding entity, primarily focuses on delivering residential and day care solutions for the elderly population across Hong Kong. The organization offers an extensive array of residential care services for seniors, encompassing lodging, expert nursing and attentive care, dietary oversight, medical assistance, physical and occupational therapy, psychological and social wellness programs, individualized attention, and recreational pursuits. Furthermore, it supplies residents with healthcare and medical goods and provides supplementary health services. Beyond its core offerings, the company also administers home care support services, engages in property investments, and furnishes property management solutions. As of March 31, 2022, it managed eight dedicated care and attention homes for seniors, providing a total of 1,129 residential spots across four distinct Hong Kong districts. These facilities operate under diverse brand names, including Fai To, Kato, Happy Luck Home, Tsuen Wan Centre, and Pine Villa. Established in 1991, the firm is based in Tuen Mun, Hong Kong, and functions as a subsidiary of Sheung Fung Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.09% | -4.21% | -6.19% | -1.09% | +3.41% | +1.11% | -5.21% | -25.41% | -27.78% | -18.75% | -18.75% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+11.6% ★ Q1'26: +31.8% (vs Q1'24)
-
EPS growth Medical - Care Facilities: +19.2%+56.2% ★ Q1'26: -83.7% (vs Q1'24)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+27.7% ★ Q1'26: +26.2% (vs Q1'24)
-
EBIT margin Medical - Care Facilities: +11.3%+18.0% ★ Q1'26: +11.1% (vs Q1'24)
-
ROIC Medical - Care Facilities: +6.8%+7.0% ★ Q1'26: +7.2% (vs Q1'24)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +0.7% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.27× Q1'26: 1.30× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
196.10M
est: 201.00M (-2.4%)
|
256.53M
est: 231.00M (+11.1%)
|
320.34M
est: 266.00M (+20.4%)
|
408.30M
est: 306.00M (+33.4%)
|
271.33M
est: 352.02M (-22.9%)
|
317.11M
est: 201.00M (+57.8%)
|
201.00M
201.00M – 201.00M
+0.0% YoY
|
231.00M
231.00M – 231.00M
+14.9% YoY
|
266.00M
266.00M – 266.00M
+15.2% YoY
|
| EBITDA |
90.90M
est: 93.40M (-2.7%)
|
131.88M
est: 107.34M (+22.9%)
|
161.67M
est: 123.60M (+30.8%)
|
206.90M
est: 131.15M (+57.8%)
|
133.61M
est: 154.89M (-13.7%)
|
96.84M
est: 93.40M (+3.7%)
|
93.40M
93.40M – 93.40M
+0.0% YoY
|
107.34M
107.34M – 107.34M
+14.9% YoY
|
123.60M
123.60M – 123.60M
+15.2% YoY
|
| EBIT |
62.86M
est: 66.09M (-4.9%)
|
99.85M
est: 75.95M (+31.5%)
|
125.10M
est: 87.46M (+43.0%)
|
162.26M
est: 91.07M (+78.2%)
|
85.98M
est: 108.61M (-20.8%)
|
47.56M
est: 66.09M (-28.0%)
|
66.09M
66.09M – 66.09M
+0.0% YoY
|
75.95M
75.95M – 75.95M
+14.9% YoY
|
87.46M
87.46M – 87.46M
+15.2% YoY
|
| Net Income |
47.87M
est: 50.00M (-4.3%)
|
79.87M
est: 60.00M (+33.1%)
|
98.94M
est: 70.00M (+41.3%)
|
126.15M
est: 72.87M (+73.1%)
|
64.19M
est: 98.51M (-34.8%)
|
21.88M
est: 50.00M (-56.2%)
|
50.00M
50.00M – 50.00M
+0.0% YoY
|
60.00M
60.00M – 60.00M
+20.0% YoY
|
70.00M
70.00M – 70.00M
+16.7% YoY
|
| SGA |
18.39M
est: 15.07M (+22.1%)
|
24.60M
est: 17.32M (+42.0%)
|
29.74M
est: 19.94M (+49.1%)
|
45.82M
est: 140.49M (-67.4%)
|
18.25M
est: 161.88M (-88.7%)
|
2.10M
est: 15.07M (-86.1%)
|
15.07M
15.07M – 15.07M
+0.0% YoY
|
17.32M
17.32M – 17.32M
+14.9% YoY
|
19.94M
19.94M – 19.94M
+15.2% YoY
|
| EPS |
0.05
est: 0.05 (+0.8%)
|
0.08
est: 0.06 (+33.2%)
|
0.10
est: 0.07 (+41.3%)
|
0.13
est: 0.08 (+56.9%)
|
0.06
est: 0.10 (-34.5%)
|
0.02
est: 0.05 (-56.2%)
|
0.05
0.05 – 0.05
+0.0% YoY
|
0.06
0.06 – 0.06
+20.0% YoY
|
0.07
0.07 – 0.07
+16.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-28 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-27 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-26 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-21 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-20 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-19 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-18 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-14 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-12 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Shi Shing Ngai | Chief Executive Officer & Executive Chairman of the Board | 2M | male |
| Ka Yee Ngai | Executive Director | 1M | female |
| Kwok Wo Lau | Executive Director | 1M | male |
| Chi Kan Kwok | Company Secretary & Chief Financial Officer | — | male |
| Mei Ping Kwong | Head of Nursing Department | — | female |
| Wai Ping Kwong | Head of Quality Control Department | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2189.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
